Skip to main content

Find Clinical Trials

Home
Conditions
Colorectal Cancer (CRC)

Clinical trial condition

Colorectal Cancer (CRC)

Explore clinical trials studying Colorectal Cancer (CRC). Study availability and eligibility vary by location and protocol.

101 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Colorectal Cancer (CRC) trial results

Recruiting

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

NCT06822413

Conditions: Adenocarcinoma, Adenoma Colon Polyp, Cancer Diagnosis, +47 more
Locations: The First Affiliated Hospital to Nanchang University Nanchang, Jiangxi, China

The Second Affiliated Hospital to Nanchang University Nanchang, Jiangxi, China

Huashan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China

The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Spatial RadiomIcs and TRanscriptomics to the DIscovery of the Cross-link Between Colon Cancer and ChrOnic Kidney Disease

NCT06886282

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +9 more
Locations: Radiology Division Naples, Italy

View Trial Details

Recruiting

Effects of Endocrine Disruptors on the Gut Microbiota and Assessment of Their Impact on Colorectal Cancer Development (PERMICA)

NCT06809660

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +14 more
Locations: CHU de Poitiers Poitiers, France

View Trial Details

Recruiting

Advances in Imaging to Assess Response in Rectal Cancer

NCT06822634

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer (CRC), +10 more
Locations: Beatson West of Scotland Cancer Centre Glasgow, United Kingdom

View Trial Details

Recruiting

Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.

NCT06640166

Conditions: Colon Adenocarcinoma, Colon Cancer, Colon Carcinoma, +18 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

Fondazione Policlinico Universitario Agostino Gemelli, IRCCS Roma, Italy

Ospedale Cardinale G. Panico Tricase, Italy

View Trial Details

Recruiting

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

NCT06751966

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +9 more
Locations: First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

The First Hospital of Nanchang Nanchang, Jiangxi, China

View Trial Details

Recruiting

Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

NCT06751953

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +9 more
Locations: First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

The First Hospital of Nanchang Nanchang, Jiangxi, China

View Trial Details

Recruiting

Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

NCT06751914

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +9 more
Locations: First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

The First Hospital of Nanchang Nanchang, Jiangxi, China

View Trial Details

Recruiting

Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

NCT06751940

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +9 more
Locations: First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

The First Hospital of Nanchang Nanchang, Jiangxi, China

View Trial Details

Recruiting

Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer

NCT06718738

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +9 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details